Royal Marsden Hospital

The Royal Marsden is the world's first hospital dedicated entirely to the study and treatment of cancer, founded in 1851 by surgeon William Marsden. With sites in Chelsea, London, and Sutton, Surrey, the hospital has spent over 170 years pioneering advances in cancer diagnosis, treatment, and research, treating around 50,000 patients from the UK and abroad every year.

The Royal Marsden works in close partnership with the Institute of Cancer Research (ICR), together ranking among the top four cancer research and treatment centres worldwide. Their joint Drug Development Unit is one of the largest phase I clinical trial centres globally, giving patients access to cutting-edge, molecularly-guided treatment programmes years ahead of standard care. The Royal Marsden is rated "Outstanding" by the Care Quality Commission and has been named Best Private Hospital by LaingBuisson two years running.

Through its dedicated International Patient Centre, the Royal Marsden offers overseas patients comprehensive multilingual support, private care combined with NHS-level safety standards, and access to world-renowned multidisciplinary cancer specialists — making it one of the most trusted destinations globally for complex cancer care.